The global infection control market is projected to reach USD 58.3 billion by 2027 from an estimated USD 50.0 billion in 2022, at a CAGR of 3.1% during the forecast period. Growth in the infection control market can largely be attributed to factors such as the growing focus on food sterilization and disinfection, rise in surgical procedures, technological advancements in sterilization equipment, and the increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1084
The endoscope reprocessing product is expected to register the highest growth during the forecast period.
Based on product and service, the market is further classified into sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, and other infection control products. The endoscope reprocessing product segment is expected to register the highest growth during the forecast period. The endoscope reprocessing market is witnessing growth due to the growing importance of diagnostic and therapeutic endoscopy procedures, the rising incidence of target diseases, the growing geriatric population and the subsequent increase in endoscopic procedures.
The contract sterilization services accounted for the second largest share of the market during the forecast period.
Based on sterilization products and services, the infection control market is segmented into sterilization equipment, contract sterilization services, and consumables and accessories. In 2021, the contract sterilization services accounted for the second largest share of the sterilization products and services market. The large share of the segment is attributed to the stringent sterilization regulations, high costs involved in in-house sterilization, and cost-containment issues compelling OEMs to reduce in-house work and outsource their sterilization requirements to third-party service providers.
The disinfectants is expected to register the highest CAGR during the forecast period.
Based on cleaning and disinfection products, the infection control market is segmented into lubricants & cleaning solutions, disinfectants, cleaning & disinfection equipment, and disinfection & cleaning accessories. The disinfectants segment is expecte to register the highest CAGR during the forecast period. This can be attributed to growing demand of disinfectants in various end-user segments, their increased usage to disinfect surfaces, patient rooms, operation theaters, hospital premises, and medical equipment in order to reduce the incidence of nosocomial infections, and rise in demand in the food industry, owing to the high risks associated with food-borne pathogens.
The endoscope reprocessing consumables holds the largest market share during the forecast period.
Based on endoscope reprocessing products, the infection control market is segmented into endoscope reprocessing equipment, endoscope reprocessing consumables, and other endoscope reprocessing products. The endoscope reprocessing consumables segment accounted for the largest share of the market during the forecast period.
The hospitals and clinics segment is expected to register the highest growth during the forecast period.
Based on end users, the market is segmented into pharmaceutical companies, hospitals and clinics, medical device companies, life sciences industry, food industry, and other end users (cosmetic industry, dietary supplement manufacturers, the veterinary industry, and other healthcare providers such as long-term care facilities and diagnostic & imaging centers). the hospitals & clinics segment is expected to register the highest growth in the market.
Enquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1084
Europe accounted for the second largest share of the infection control market
Europe accounted for the second largest share of the infection control market. The region's large share can be attributed to the growing number of surgeries performed annually, primarily due to the rising geriatric population and the growing prevalence of lifestyle diseases such as obesity and CVD.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%
Key players in the Infection Control market
The key players operating in the infection control market include Pal International (UK), Advanced Sterilization Products (US), Sotera Health Company (US), MMM Group (Germany), Matachana Group (Spain), Belimed AG (Switzerland), Metrex Research LLC (US), Reckitt Benckiser (UK), Melag Medizintechnik GmbH & Co. KG (Germany), The Miele Group (Germany), Systec GmbH (Germany), Getinge AB (Sweden), Ecolab, Inc. (US),3M Company (US), MEDALKAN (Greece), Dr. Schumacher GmbH (Germany), Contec,Inc. (US), Continental Equipment Company (US), Steris Plc (US), Acto GmbH (Germany), C.B.M. S.R.L. Medical Equipment (Italy), Spire Integrated Solutions (US), Consolidated Sterilizer Systems (US), Ultrawave (UK), and ARC Healthcare Solutions (Canada).
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1084
Related Reports:
About MarketsandMarkets™
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek